Another rise is forming for Aeolus Pharmaceuticals Inc. (OTC:AOLS), only this time it is not the result of promotions as in February. Back then, the money paid was worth the sharp jump of the stock price. Will it happen again is the question at hand now, since the volumes already surpass the ones sparkled by promoters a little. 
Now, as mentioned, it is not promotions that set the market on fire this week. Neither are there any announcements from the company, nor financial statements. Yet, there is news to come. Today, the company’s CEO will present a corporate update, which might heighten tensions on the stock market even more. The volume of traded shares yesterday reached 565k, while the price jumped from $0.61 on Monday to $0.72 on the next day.Â
The truth of the matter is that there is still much to be done before a trend of stability is formed on the market. The latest financial statements are not exactly inspiring, despite the $116 million grant from a contract with the Biomedical Advanced Research and Development Authority (BARDA). While this is certainly good news, the real value is not in the money, but in the way it would be used to develop a marketable product. [BANNER]
After all, a government grant can help, but does not necessarily mean higher revenues in the future. Since Mr. John McManus will report on how Aeolus is performing, it might be a good idea to take a closer look at the presentation, especially since it will be available through the company’s website as well.
The words of the CEO are likely to provide a clue as to how the stock would move on the market for the days and maybe weeks and months to come. One thing is clear – the trading frenzy that is coming might not only surpass the one from February, for which solid cash was paid to promoters, but hit an all-time high.
